Cara Tomas

Cara Tomas, PhD, is a Postdoctoral Research Associate at the Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Tomas' interest in ME/CFS stems from her own experience with acute onset ME/CFS leaving her bedbound for a time.

Notable studies

 * 2017, Cellular bioenergetics is impaired in patients with chronic fatigue syndrome - (Full Text)
 * 2017, Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study - (Full Text)
 * 2018, Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review - (Abstract)
 * 2018, A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy - (Abstract)
 * 2019, MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: A study of mildly deleterious variants - (Full text)
 * 2019, The role of mitochondria in ME/CFS: a perspective - (Abstract)
 * 2019, Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types - (Full text)
 * 2019, Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test - (Full text)
 * 2020, The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function - (Full text)
 * 2020, Substrate utilisation of cultured skeletal muscle cells in patients with CFS - (Full text)

Talks and interviews

 * 4 May 2018 -Speaker at ME/CFS Canadian Collaborative Team Conference - Cellular Bioenergetics is Impaired in Patients with ME/CFS
 * 20 Sep 2018 - Speaker at UK CFS/ME Research Collaborative Conference; Title - Cellular bioenergetics in ME/CFS

Online presence

 * LinkedIn

Learn more

 * We hear from Cara Tomas about her recent study on cellular bioenergetic deficiencies in ME/CFS | 13 November 2017 by the ME Association
 * Blood cells in chronic fatigue syndrome are drained of energy by Andy Coghlan for New Scientist